This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curtin, J.
Right arrow Articles by Colleran, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtin, J.
Right arrow Articles by Colleran, E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2003, p. 3145-3148, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3145-3148.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Linezolid Compared with Eperezolid, Vancomycin, and Gentamicin in an In Vitro Model of Antimicrobial Lock Therapy for Staphylococcus epidermidis Central Venous Catheter-Related Biofilm Infections

John Curtin,1* Martin Cormican,2 Gerard Fleming,1 John Keelehan,3 and Emer Colleran1

Department of Microbiology,1 Department of Bacteriology, National University of Ireland,2 Department of Medical Microbiology, University College Hospital, Galway, Ireland3

Received 27 March 2003/ Returned for modification 30 April 2003/ Accepted 3 July 2003

Central venous catheter (CVC)-related infection (CVC-RI) is a common complication of CVC use. The most common etiological agents of CVC-RI are gram-positive organisms, in particular, staphylococci. An in vitro model for the formation of biofilms by Staphylococcus epidermidis ATCC 35984 on polyurethane coupons in a modified Robbins device was established. Biofilm formation was confirmed by electron microscopy and was quantified by determination of viable counts. Mueller-Hinton broth was replaced with sterile physiological saline (control) or a solution of vancomycin (10 mg/ml), gentamicin (10 mg/ml), linezolid (2 mg/ml), or eperezolid (4 mg/ml). Viable counts were performed with the coupons after exposure to antimicrobials for periods of 24, 72, 168, and 240 h. The mean viable count per coupon following establishment of the biofilm was 4.6 x 108 CFU/coupon, and that after 14 days of exposure to physiological saline was 2.5 x 107 CFU/coupon. On exposure to vancomycin (10 mg/ml), the mean counts were 2.5 x 107 CFU/coupon at 24 h, 4.3 x 106 CFU/coupon at 72 h, 1.4 x 105 CFU/coupon at 168 h, and undetectable at 240 h. With gentamicin (10 mg/ml) the mean counts were 2.7 x 107 CFU/coupon at 24 h, 3.7 x 106 CFU/coupon at 72 h, 8.4 x 106 CFU/coupon at 168 h, and 6.5 x 106 CFU/coupon at 240 h. With linezolid at 2 mg/ml the mean counts were 7.1 x 105 CFU/coupon at 24 h and not detectable at 72, 168, and 240 h. With eperezolid (4 mg/ml) no viable cells were recovered after 168 h. These data suggest that linezolid (2 mg/ml) and eperezolid (4 mg/ml) achieve eradication of S. epidermidis biofilms more rapidly than vancomycin (10 mg/ml) and gentamicin (10 mg/ml).

* Corresponding author. Mailing address: Department of Microbiology, National University of Ireland, Galway, Galway, Ireland. Phone: 353 (0)91 524411, ext. 3782. Fax: 353 (0)91 525700. E-mail: john.curtin{at}nuigalway.ie.

Antimicrobial Agents and Chemotherapy, October 2003, p. 3145-3148, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3145-3148.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hendry, E. R., Worthington, T., Conway, B. R., Lambert, P. A. (2009). Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J Antimicrob Chemother 64: 1219-1225 [Abstract] [Full Text]  
  • Qu, Y., Istivan, T. S., Daley, A. J., Rouch, D. A., Deighton, M. A. (2009). Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 58: 442-450 [Abstract] [Full Text]  
  • Fennell, J. P., O'Donohoe, M., Cormican, M., Lynch, M. (2008). Linezolid lock prophylaxis of central venous catheter infection. J Med Microbiol 57: 534-535 [Abstract] [Full Text]  
  • Lee, M. Y., Ko, K. S., Song, J.-H., Peck, K. R. (2007). In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother 60: 782-787 [Abstract] [Full Text]  
  • LaPlante, K. L., Mermel, L. A. (2007). In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 22: 2239-2246 [Abstract] [Full Text]  
  • Raad, I., Hanna, H., Jiang, Y., Dvorak, T., Reitzel, R., Chaiban, G., Sherertz, R., Hachem, R. (2007). Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm. Antimicrob. Agents Chemother. 51: 1656-1660 [Abstract] [Full Text]  
  • Aslam, S., Trautner, B. W., Ramanathan, V., Darouiche, R. O. (2007). Combination of Tigecycline and N-Acetylcysteine Reduces Biofilm-Embedded Bacteria on Vascular Catheters. Antimicrob. Agents Chemother. 51: 1556-1558 [Abstract] [Full Text]  
  • Gualtieri, M., Bastide, L., Villain-Guillot, P., Michaux-Charachon, S., Latouche, J., Leonetti, J.-P. (2006). In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. J Antimicrob Chemother 58: 778-783 [Abstract] [Full Text]  
  • Fortun, J., Grill, F., Martin-Davila, P., Blazquez, J., Tato, M., Sanchez-Corral, J., Garcia-San Miguel, L., Moreno, S. (2006). Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 58: 816-821 [Abstract] [Full Text]  
  • Lee, J.-Y., Ko, K. S., Peck, K. R., Oh, W. S., Song, J.-H. (2006). In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 57: 1110-1115 [Abstract] [Full Text]  
  • Fernandez-Hidalgo, N., Almirante, B., Calleja, R., Ruiz, I., Planes, A. M., Rodriguez, D., Pigrau, C., Pahissa, A. (2006). Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57: 1172-1180 [Abstract] [Full Text]  
  • Curtin, J. J., Donlan, R. M. (2006). Using Bacteriophages To Reduce Formation of Catheter-Associated Biofilms by Staphylococcus epidermidis.. Antimicrob. Agents Chemother. 50: 1268-1275 [Abstract] [Full Text]  
  • Castagnola, E., Moroni, C., Gandullia, P., Oddone, M., Peri, C., Casciaro, R., De Alessandri, A. (2006). Catheter Lock and Systemic Infusion of Linezolid for Treatment of Persistent Broviac Catheter-Related Staphylococcal Bacteremia. Antimicrob. Agents Chemother. 50: 1120-1121 [Full Text]  
  • Rijnders, B. J., Van Wijngaerden, E., Vandecasteele, S. J., Stas, M., Peetermans, W. E. (2005). Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55: 90-94 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»